Pharmabiz

Santaana Fertility to Expand Network in partnership, investing Rs. 50 crore

Santaana Fertility is partnering with Magnet Hospitals, marking a new phase in the fertility chain’s journey. Under this ...
PharmabizOpinion

India's pharma, healthcare manufacturing ambitions need stronger stainless steel ecosystem, dedicated policy support: ISSDA

India's pharma, healthcare manufacturing ambitions need stronger stainless steel ecosystem, dedicated policy support: ISSDA: ...
Pharmabiz

Taiho Innovations begins operation under new organizational structure

Taiho Innovations begins operation under new organizational structure: Tokyo Saturday, July 4, 2026, 14:00 Hrs [IST] Taiho Pharmaceutical Co., Ltd. and Taiho Innovations Ltd. are ...
Pharmabiz

Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India

Zydus signs MoU with Apollo Hospitals to expand access to the Shield Multi-Cancer Detection test in India: Our Bureau, Mumbai Saturday, July 4, 2026, 11:45 Hrs [IST] Zydus Lifesci ...
Pharmabiz

Slow Burn Method opens registrations for the next cohort of its flagship 'Take Control' weight management programme

Slow Burn Method opens registrations for the next cohort of its flagship 'Take Control' weight management programme: Our Bureau, Mumbai Saturday, July 4, 2026, 12:30 Hrs [IST] Slo ...
Pharmabiz

Glenmark advances phase 3 clinical trial of trastuzumab rezetecan in platinum-resistant ovarian cancer

Glenmark advances phase 3 clinical trial of trastuzumab rezetecan in platinum-resistant ovarian cancer: Our Bureau, Mumbai Saturday, July 4, 2026, 12:15 Hrs [IST] Glenmark Special ...
Pharmabiz

Symeres and Axxam appoint Russell Thomas as CSO

Symeres, a leading contract research, development and manufacturing organization, and Axxam, a leading provider of biology-driven discovery services, announced the appointment of Russell Thomas, Ph.D.
Pharmabiz

Celea Therapeutics completes $180 million financing

PureTech Health plc, a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, is pleased to note that its founded entity Celea Therapeutics ...
Pharmabiz

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification

Hutchmed receives China NMPA conditional approval for Orpathys to treat gastric cancer patients with MET amplification: Hong Kong, Shanghai Saturday, July 4, 2026, 11:00 Hrs [IST] ...
Pharmabiz

Bajaj Broking Prive Research reports tailwinds driving capex in anticipation of growth in Indian healthcare

Bajaj Broking Prive Research reports that tailwinds are seen to propel capex in anticipation of growth in India’s healthcare sector which is undergoing an explosive transformation. The capital ...
Pharmabiz

Newron Pharmaceuticals provides update following Type A meeting with the US FDA

Newron Pharmaceuticals provides update following Type A meeting with the US FDA: Milan, Italy Saturday, July 4, 2026, 10:00 Hrs [IST] Newron Pharmaceuticals S.p.A. (Newron), a bio ...
Pharmabiz

MDC seeks further evidence to decide on exemption of antiseptic Povidone Iodine throat spray from DPCO

MDC seeks further evidence to decide on exemption of antiseptic Povidone Iodine throat spray from DPCO: Gireesh Babu, New Delhi Saturday, July 4, 2026, 08:00 Hrs [IST] The Multi-D ...